Go Pro

PMV Pharmaceuticals (PMVP) Institutional Ownership

PMV Pharmaceuticals logo
$1.25 +0.03 (+2.47%)
As of 01:35 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for PMV Pharmaceuticals (NASDAQ:PMVP)

Current
Institutional Ownership
Percentage
90.20%
Number of
Institutional Buyers
(last 12 months)
25
Total
Institutional Inflows
(last 12 months)
$7.46M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$3.56M
Get PMVP Insider Trade Alerts

Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PMVP Institutional Buying and Selling by Quarter

PMV Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2026Connor Clark & Lunn Investment Management Ltd.32,460$43K0.0%N/A0.061%
8/7/2026 BlackRock Inc.919,818$1.23M0.0%N/A1.725%
8/3/2026 Walleye Capital LLC335,694$450K0.0%N/A0.629%
7/8/2026 Assenagon Asset Management S.A.330,003$442K0.0%-8.5%0.619%
5/18/2026ADAR1 Capital Management LLC231,008$286K0.0%+128.7%0.433%
5/18/2026Eversept Partners LP2,348,360$2.91M0.2%N/A4.403%
5/15/2026Rangeley Capital LLC66,846$83K0.1%+46.9%0.125%
5/6/2026 BML Capital Management LLC5,320,000$6.60M4.2%+0.5%9.976%
4/20/2026 Assenagon Asset Management S.A.360,786$447K0.0%+156.8%0.677%
2/26/2026Seven Fleet Capital Management LP63,498$79K0.1%N/A0.119%
2/18/2026XTX Topco Ltd104,485$131K0.0%+144.3%0.196%
2/18/2026Tang Capital Management LLC4,940,000$6.18M0.3%+3.2%9.284%
2/18/2026Orbimed Advisors LLC4,975,291$6.22M0.1%-16.7%9.350%
2/18/2026Boothbay Fund Management LLC27,126$34K0.0%-86.5%0.051%
2/18/2026Bridgeway Capital Management LLC428,853$536K0.0%+33.7%0.806%
2/17/2026ArrowMark Colorado Holdings LLC3,090,093$3.86M0.1%-6.4%5.807%
2/17/2026Public Employees Retirement System of Ohio27,434$34K0.0%+349.7%0.052%
2/17/2026RBF Capital LLC162,200$203K0.0%-33.9%0.305%
2/16/2026Squarepoint Ops LLC26,502$33K0.0%+101.8%0.050%
2/13/2026Marshall Wace LLP465,086$581K0.0%-24.1%0.874%
2/13/2026 Walleye Capital LLC335,694$420K0.0%+20.6%0.631%
2/13/2026 State Street Corp183,178$229K0.0%+16.2%0.344%
2/12/2026Jane Street Group LLC498,641$623K0.0%+30.5%0.937%
2/12/2026Aldebaran Capital LLC477,988$597K0.5%-5.2%0.898%
2/10/2026Goldman Sachs Group Inc.127,041$159K0.0%-25.6%0.239%
2/9/2026 Geode Capital Management LLC446,140$558K0.0%+3.3%0.838%
1/9/2026 Assenagon Asset Management S.A.140,468$176K0.0%+14.1%0.264%
11/17/2025Jacobs Levy Equity Management Inc.68,668$96K0.0%N/A0.129%
11/17/2025Susquehanna International Group LLP25,634$36K0.0%-42.7%0.048%
11/17/2025Citadel Advisors LLC193,153$270K0.0%-24.7%0.363%
11/17/2025Bank of America Corp DE162,496$227K0.0%+457.5%0.305%
11/17/2025Boothbay Fund Management LLC201,498$282K0.0%N/A0.379%
11/17/2025ArrowMark Colorado Holdings LLC3,301,341$4.62M0.1%+3.6%6.204%
11/17/2025Algert Global LLC62,020$87K0.0%N/A0.117%
11/14/2025Orbimed Advisors LLC5,975,291$8.37M0.2%-7.7%11.276%
11/14/2025Two Sigma Investments LP269,621$377K0.0%-7.5%0.509%
11/14/2025Bridgeway Capital Management LLC320,653$449K0.0%+115.5%0.605%
11/10/2025Aldebaran Capital LLC504,128$706K0.6%-2.1%0.951%
11/10/2025 Peapod Lane Capital LLC202,784$284K0.3%-55.2%0.383%
11/10/2025 BML Capital Management LLC5,292,000$7.41M5.7%+5.8%9.987%
These gold assets are priced for $1,800 gold [it's over $4,000] (Ad)

Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.tc pixel

See the junior gold assets majors may target next
11/7/2025Vanguard Group Inc.2,163,027$3.03M0.0%+0.4%4.082%
11/7/2025 PNC Financial Services Group Inc.71,006$99K0.0%+16.7%0.134%
10/7/2025 Assenagon Asset Management S.A.123,092$172K0.0%-53.2%0.232%
8/15/2025Shay Capital LLC24,310$26K0.0%N/A0.046%
8/13/2025 Walleye Capital LLC77,887$83K0.0%-23.4%0.147%
8/13/2025Stonepine Capital Management LLC845,968$897K0.9%+34.2%1.596%
8/11/2025 BML Capital Management LLC5,000,000$5.30M4.0%+33.4%9.624%
8/7/2025Acadian Asset Management LLC2,066,137$2.19M0.0%+0.9%3.977%
7/31/2025 Peapod Lane Capital LLC452,682$480K0.5%-7.5%0.871%
7/11/2025 Assenagon Asset Management S.A.263,059$279K0.0%+128.7%0.506%
6/27/2025Goldman Sachs Group Inc.90,263$98K0.0%-25.6%0.174%
5/21/2025Acadian Asset Management LLC2,047,177$2.23M0.0%-1.5%3.940%
5/16/2025Goldman Sachs Group Inc.90,263$98K0.0%-25.6%0.174%
5/16/2025Jacobs Levy Equity Management Inc.129,914$142K0.0%-75.9%0.250%
5/14/2025Stonepine Capital Management LLC630,183$687K0.7%+17.6%1.213%
5/14/2025Walleye Capital LLC101,696$111K0.0%-20.3%0.196%
5/13/2025Aldebaran Capital LLC523,553$571K0.5%+4.3%1.008%
5/12/2025Connor Clark & Lunn Investment Management Ltd.267,636$292K0.0%-27.8%0.515%
5/7/2025BML Capital Management LLC3,747,612$4.09M3.1%+8.1%7.214%
4/30/2025Peapod Lane Capital LLC489,370$533K0.6%+9.8%0.942%
4/15/2025Assenagon Asset Management S.A.115,038$125K0.0%-25.2%0.222%
2/17/2025Velan Capital Investment Management LP35,000$53K0.0%N/A0.068%
2/17/2025Squarepoint Ops LLC73,015$110K0.0%+68.7%0.141%
2/17/2025Two Sigma Investments LP506,986$766K0.0%+5.0%0.980%
2/17/2025Two Sigma Advisers LP714,600$1.08M0.0%-4.9%1.381%
2/17/2025Stonepine Capital Management LLC535,805$809K0.7%N/A1.035%
2/17/2025Shay Capital LLC156,451$236K0.0%-16.8%0.302%
2/17/2025Millennium Management LLC318,020$480K0.0%-12.6%0.615%
2/17/2025Jacobs Levy Equity Management Inc.539,893$815K0.0%-23.5%1.043%
2/17/2025D. E. Shaw & Co. Inc.1,024,288$1.55M0.0%-1.6%1.979%
2/17/2025Bridgeway Capital Management LLC202,100$305K0.0%+44.5%0.391%
2/17/2025Bank of America Corp DE44,568$67K0.0%-63.1%0.086%
2/17/2025Ameriprise Financial Inc.22,807$34K0.0%-42.3%0.044%
2/17/2025ArrowMark Colorado Holdings LLC3,508,451$5.30M0.1%-3.8%6.780%
2/14/2025Jane Street Group LLC49,870$75K0.0%-32.7%0.096%
2/14/2025Schonfeld Strategic Advisors LLC35,200$53K0.0%-47.4%0.068%
2/14/2025Northern Trust Corp107,340$162K0.0%+23.2%0.207%
2/14/2025RBF Capital LLC245,561$380K0.0%-3.1%0.475%
2/13/2025Walleye Capital LLC127,626$193K0.0%-12.4%0.247%
2/12/2025Aldebaran Capital LLC502,190$758K0.7%+14.6%0.970%
2/12/2025Geode Capital Management LLC421,710$637K0.0%-2.6%0.815%
2/12/2025JPMorgan Chase & Co.24,591$37K0.0%+2,282.8%0.048%
2/10/2025Connor Clark & Lunn Investment Management Ltd.370,920$560K0.0%-15.9%0.717%
2/7/2025BML Capital Management LLC3,466,684$5.24M3.3%+105.3%6.699%
1/29/2025Peapod Lane Capital LLC445,744$673K0.7%N/A0.861%
1/14/2025Assenagon Asset Management S.A.153,701$232K0.0%-56.6%0.297%
11/20/2024Virtu Financial LLC28,146$42K0.0%N/A0.054%
11/19/2024Barclays PLC30,248$45K0.0%-93.5%0.058%
11/15/2024M&T Bank Corp399,548$596K0.0%+54.6%0.772%
11/15/2024Barclays PLC30,248$45K0.0%-93.5%0.058%
These gold assets are priced for $1,800 gold [it's over $4,000] (Ad)

Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.tc pixel

See the junior gold assets majors may target next
11/15/2024XTX Topco Ltd24,160$36K0.0%-83.6%0.047%
11/15/2024Jane Street Group LLC74,089$110K0.0%-54.8%0.143%
11/15/2024Jacobs Levy Equity Management Inc.705,593$1.05M0.0%-9.4%1.364%
11/15/2024ArrowMark Colorado Holdings LLC3,647,291$5.43M0.1%+30.0%7.048%
11/15/2024Point72 Asia Singapore Pte. Ltd.32,190$48K0.0%-48.6%0.062%
11/14/2024PFM Health Sciences LP2,011,040$3.00M0.2%+57.7%3.886%
11/14/2024Sio Capital Management LLC3,214,239$4.79M1.9%+18.7%6.211%
11/5/2024BML Capital Management LLC1,688,772$2.52M1.5%+29.0%3.278%
10/23/2024Assenagon Asset Management S.A.353,837$527K0.0%+36.1%0.687%
9/16/2024Cubist Systematic Strategies LLC69,867$113K0.0%+570.8%0.136%


PMVP Institutional Ownership - Frequently Asked Questions

During the previous two years, 52 institutional investors and hedge funds held shares of PMV Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($6.60M), Orbimed Advisors LLC ($6.22M), Tang Capital Management LLC ($6.18M), Sio Capital Management LLC ($4.79M), ArrowMark Colorado Holdings LLC ($3.86M), Vanguard Group Inc. ($3.03M), and PFM Health Sciences LP ($3.00M).Learn more on PMV Pharmaceuticals' institutional investors.

90.20% of PMV Pharmaceuticals' stock is owned by institutional investors. Learn more on PMVP's institutional investor holdings.

Of the 40 institutional investors that purchased PMV Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($4.01M), Eversept Partners LP ($2.35M), ArrowMark Colorado Holdings LLC ($955.73K), BlackRock Inc. ($919.82K), Stonepine Capital Management LLC ($845.97K), PFM Health Sciences LP ($735.58K), and Sio Capital Management LLC ($505.83K).

Institutional investors have bought a total of 5,776,575 shares in the last 24 months. This purchase volume represents approximately $7.46M in transactions.

Of the 12 institutional investors that sold PMV Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Orbimed Advisors LLC ($1.50M), Peapod Lane Capital LLC ($249.90K), ArrowMark Colorado Holdings LLC ($211.25K), Boothbay Fund Management LLC ($174.37K), Assenagon Asset Management S.A. ($170.75K), Marshall Wace LLP ($147.54K), and RBF Capital LLC ($83.36K).

Institutional investors have sold a total of 2,722,306 shares in the last 24 months. This volume of shares sold represents approximately $3.56M in transactions.



Institutional ownership data for NASDAQ:PMVP is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/13/2026. New 13F filings are added each quarter as they're published.
From Our Partners